HIVEP2
protein-codingHIVEP zinc finger 2, the group of Zinc fingers C2H2-type
Gene summary
This gene encodes a member of a family of closely related, large, zinc finger-containing transcription factors. The encoded protein regulates transcription by binding to regulatory regions of various cellular and viral genes that maybe involved in growth, development and metastasis. The protein contains the ZAS domain comprised of two widely separated regions of zinc finger motifs, a stretch of highly acidic amino acids and a serine/threonine-rich sequence. [provided by RefSeq, Nov 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~205.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0015802
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014858
Submitter: Illumina
The HIVEP2 gene was first reported in relation to autosomal dominant HIVEP2-related intellectual disability in 2012 (23020937: Rauch et al. 2012). At least six unique variants have been reported in three papers, all of which are de novo, loss of function variants (four null, and two frameshift variants) (23020937: Rauch et al. 2012; 26153216: Srivastava et al. 2016; 27003583: Steinfeld et al. 2016). Evidence supporting this gene-disease relationship includes case-level data and experimental data. More evidence is available in the literature, but the maximum score for genetic evidence experimental evidence (12 pts.) has been reached. This gene-disease relationship is supported by a homozygous knockout mouse model which exhibited anxiety, increased stress, cognitive impairment, hyperactivity and other brain anomalies; and studies showing interaction with, and expression in the developing brain and co-localisation with, SEF2 (now TCF4), a gene associated with intellectual disability. In summary, there is strong evidence to support the relationship between HIVEP2 and HIVEP2-related intellectual disability (autosomal dominant). Additional reports in humans are needed to reach a definitive classification
Inheritance Pattern: AD
Disease ID:MONDO:0014858
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014858
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014858
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HIVEP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006734.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 261 | 109 | 378 | ||
| missense | 1 | 4 | 663 | 328 | 28 | 1024 |
| nonsense | 27 | 6 | 4 | 37 | ||
| start loss | 0 | |||||
| frameshift | 27 | 20 | 2 | 1 | 50 | |
| splice donor/acceptor (+/-2bp) | 2 | 1 | 3 | |||
| Total | 55 | 32 | 678 | 590 | 137 | 1492 |
Highest pathogenic variant AF is 0.0000013681145
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006725.3 | 6 | MANE Select | |
| Ensembl | ENSP00000356575.2 | 6 | MANE Select | |
| RefSeq | NP_001425378.1 | 6 | Standard | |
| RefSeq | NP_001425379.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription by RNA polymerase II
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- metal ion binding
Cellular Component
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367603
- Coding exons
- 6
- Length
- 193735
- Individuals with no LoFs
- 124789
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 7
- Defined
- 124796
- p
- 0.0000280
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.83 | 1129 | 1.32e+3 | 0.858 | 0.0000739 | 16010 |
| Missense (PolyPhen) | 317 | 516.63 | 0.61359 | 6391 | ||
| Synonymous | -0.942 | 547 | 520 | 1.05 | 0.0000319 | 4889 |
| Loss of Function | 8.02 | 2 | 78.8 | 0.0254 | 0.00000432 | 1068 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00013 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000035 | 0.000035 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: This protein specifically binds to the DNA sequence 5'- GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, somatostatin receptor II, and interferon- beta genes. It may act in T-cell activation.;
- Disease
- DISEASE: Mental retardation, autosomal dominant 43 (MRD43) [MIM:616977]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD43 patients manifest developmental delay, intellectual disability, hypotonia, and dysmorphic features. {ECO:0000269|PubMed:23020937, ECO:0000269|PubMed:26153216}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- LoFtool
- 0.0160
- RVIS EVS
- -2.2
- RVIS percentile EVS
- 1.37
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.852
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |